Skip to content
Biodatica
Start free

BPGbio

Los Angeles, California

OncologyPhase II
Compare Sign in to watch

What changed

Study registered, no phase assigned: Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients

6w agoTrial registeredJun 4, 2026Source filing (opens the source filing in a new tab)

Momentum

71no change

Momentum 71 out of 100, unchanged since the last recompute.

Accelerating: several high-weight events landed recently.

Runway (estimate)

—unknown

No disclosed raise on file, so there is nothing to model from.

Stage

Phase II

The furthest-along thing in the public record. Not a projection.

Runway is an estimate: the last disclosed raise (SEC Form D) minus a modeled burn rate for the company’s stage and therapeutic area. It is not a disclosure, and companies routinely raise non-dilutive money we can’t see. How this is calculated.

Peer position

1,126 pre-ticker oncology companies at Phase II

Peer ranking — where this company sits among its stage-and-area peers by momentum, and how its runway compares to the peer median — is part of the Analyst tier.

Compare seats

A ranking of the same momentum figure the feed publishes, computed live against public-filing peers. It is a relative position, not a recommendation, and it is identical for every viewer.

Grant to raise

Every record Biodatica has resolved onto this company, newest first, each linked to the filing it came from. Where a source publishes no stable deep link for a record, the identifier is shown so you can look it up yourself.

  1. Trial

    NA registered

    Nov 26, 2019

    Breast Cancer, Breast Cancer Stage I, Breast Cancer Stage II, Breast Cancer Stage III · ACTIVE_NOT_RECRUITING · sponsor: Memorial Sloan Kettering Cancer Center · Safety of Lower Scalp Cooling Temperature to Prevent Hair Loss From Chemotherapy in Breast Cancer Patients

    ClinicalTrials.gov · NCT04180579 (opens the source filing in a new tab)

  2. Trial

    PHASE2 registered

    Sep 14, 2018

    Breast Cancer, Hyposexual Desire Disorder · ACTIVE_NOT_RECRUITING · sponsor: Memorial Sloan Kettering Cancer Center · A Study of Flibanserin in Breast Cancer Survivors on Tamoxifen or Aromatase Inhibitors

    ClinicalTrials.gov · NCT03707340 (opens the source filing in a new tab)

  3. Trial

    PHASE1 registered

    Sep 17, 2012

    Chemotherapy-Induced Alopecia · COMPLETED · sponsor: BPGbio · Compound 31543 (Calcitriol, USP) in Patients Receiving Taxane-based Chemotherapy Regimens for the Treatment of Chemotherapy-Induced Alopecia

    ClinicalTrials.gov · NCT01588522 (opens the source filing in a new tab)

Biodatica publishes impersonal research shown identically to every subscriber. This dossier is informational only, it is not investment advice, and the momentum and runway figures are estimates derived from public filings. The underlying records are U.S. government works. Disclosures · Data sources